论文部分内容阅读
目的:观察稳心颗粒对急性心肌梗死(AMI)患者经皮冠状动脉介入治疗术(PCI)中再灌注心律失常(RA)的影响。方法:选择符合诊断标准并有直接PCI指征的AMI患者105例,随机分为治疗组及对照组,对照组在常规药物治疗上行直接PCI,治疗组在上述治疗上加用稳心颗粒,观察术中、术后RA的发生情况。结果:治疗组RA发生率(36.2%)明显低于对照组(72.3%),2组比较差异有统计学意义(P<0.01)。结论:稳心颗粒对RA尤其是室性心律失常有较好治疗和预防作用。
Objective: To observe the effect of Wenxinkeli on reperfusion arrhythmia (RA) in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). Methods: A total of 105 AMI patients with diagnostic criteria and direct PCI indications were randomly divided into treatment group and control group. The control group was treated with conventional PCI, and the treatment group was treated with Wenxin Granules. Intraoperative and postoperative RA occurred. Results: The incidence of RA in the treatment group (36.2%) was significantly lower than that in the control group (72.3%). The difference between the two groups was statistically significant (P <0.01). Conclusion: Wenxin Granule has better therapeutic and preventive effects on RA, especially ventricular arrhythmia.